Are you suggesting that the two big sellers who are jumping ahead of one another are reading this website?
Scary!
Printable View
Just had a look at depth and didnt see anything really big in the way of sales volume-(1 at 40,000)-Seems a bit early for insiders jumping ship so im finding the whole thing a bit weird--Its almost as if the news has already happened.--I guess stranger things have happened though.
Never a dull moment with PEB.
Bids a bit on the light side though
Guess you must be talking about the big sellers @ 84-85
No, didnt say he was, just suggested he should leave his tanks behind if he wanted both crays and paua.:)
Personally Im all in favour of leaving these critters in peace for a while and let them recover.
(You can read that 2 ways)
CDY much more interesting at the moment
Not only scary but unlikely, I would have thought. Any big investor would hardly want to waste time fighting through the jungle of conflicting and inane posts on this site. They'd consult their broker. It would be nice if we could be more civil to each other, even if we couldn't think of anything to say that's relevant to PEB.
Fair enough. I'm sure Snapiti would be willing to sacrifice a cattle beast for dinner. I'll bring the pumpkin pie. Miner is just up the road with the moonshine and I'm sure NBT could make a special trip in his lighter than air vehicular device to drop in.
Sound good guys? Shall we meet at mine? :D :D :D
This won’t affect the upcoming results, but may be of tangential interest to those who DTOR.
There’s been relatively heavy trading today and a slight SP rise in Aussie biotech company Cellmid, with which PEB has a close relationship, following an agreement by the world’s biggest animal health company Zoetis to buy an option to evaluate and licence Cellmid’s proprietary biomarker Midkine, which PEB uses in CxBladder. Midkine is a growth factor that modulates cell growth and is often found very early in disease onset, including cancer, even before any apparent physical symptoms.
PEB last year issued 1,084,622 milestone shares to Cellmid based on a license agreement signed in 2010 for the use of Midkine as one of the biomarkers in CxBladder. Milestone fee royalties will also be paid to Cellmid on Cxbladder revenues.
In response to NTs post--I find It always helps to look at the bigger picture--family-freinds-living in an awesome country(while the majority of the world lives in poverty) we are the fortunate ones that for some reason got born into this lucky life.
Its a paradox that what we have ,sometimes leads to the stuff we are dealing with here.
If your thinking about the share market--you've most likely got enough food for your family.(seen the poverty first hand) --- nuff said
Well, your statement appeared to involve a bit of subtlety - but didn't have the buy price so it could be put into better perspective. I honestly congratulate you for your .78c gross return but presumably this is a taxable gain (given the hold time, the taxman may see you as a trader) plus you no longer hold the shares.Quote:
lol....... the more research I do the better investor I become so happy to have sold my PEB investment for an average of $1.31:t_up:
Given everyone's philosophy is different, I often wonder why some post what their gains (or losses) are on these threads.